Application‑driven Planetary Mill segmentation reveals four principal end‑use categories. The pharmaceutical sector, responsible for approximately 40% of market volume, utilizes planetary mills for API particle size reduction and solid‑dose formulation, directly influencing drug bioavailability. Materials science accounts for 30% of demand, where mills facilitate alloy homogenization, composite matrix preparation, and bulk‑material conditioning. The nanotechnology segment contributes 20%, focusing on the synthesis of quantum dots, nanowires, and catalyst nanoparticles that require sub‑100 nm particle sizes. The residual 10% falls under other applications, encompassing academic research, forensic analysis, and prototype development. These application shares are reflected in the chartData, illustrating how each use‑case drives distinct demand patterns and informs capacity planning across the planetary mill supply chain.